Down-regulation of CD20 on B cells upon CD40 activation

被引:47
作者
Anolik, J
Looney, RJ
Bottaro, A
Sanz, I
Young, F
机构
[1] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med, Dept Immunol & Microbiol, Rochester, NY 14642 USA
关键词
CD20; CD40; B lymphocyte;
D O I
10.1002/eji.200323515
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD20 is a B cell-specific surface antigen that is thought to play an important role in B cell activation and proliferation, possibly by functioning as a calcium channel or interacting with other cell surface molecules important in B cell signal transduction, such as CD40. In this study, it was found that stimulation through CD40 caused a dramatic decrease in the expression of surface CD20 in normal human B lymphocytes. Down-regulation of CD20 was time and ligand concentration dependent, beginning as early as 15 min after incubation with CD40 ligand-transfected fibroblasts. The rapid onset of this effect in the presence of stable steady-state mRNA levels suggests that CD20 down-regulation occurs at a nontranscriptional level. Confocal fluorescent microscopy indicates that CD20 and CD40 are internalized upon CD40 activation. Specifically, CD20 translocates into lipid rafts and is internalized into cytoplasmic vesicles, in a process that is inhibited by cytochalasin B and protein kinase C antagonists. Paradoxically, one functional consequence of CD20 down-regulation was enhanced calcium signaling upon CD20 cross-linking. These observations support the notion that CD20 engages downstream signaling pathways that alter calcium homeostasis rather than functioning as a calcium channel itself, such signal transduction is enhanced upon CD20 internalization, and CD40 is a regulator of CD20-mediated signaling.
引用
收藏
页码:2398 / 2409
页数:12
相关论文
共 37 条
  • [1] Anolik IH, 2001, ARTHRITIS RHEUM, V44, pS387
  • [2] The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
    Anolik, JH
    Campbell, D
    Felgar, RE
    Young, F
    Sanz, I
    Rosenblatt, J
    Looney, RJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 455 - 459
  • [3] ADRIAMYCIN(HYDRAZONE)-ANTIBODY CONJUGATES REQUIRE INTERNALIZATION AND INTRACELLULAR ACID-HYDROLYSIS FOR ANTITUMOR-ACTIVITY
    BRASLAWSKY, GR
    KADOW, K
    KNIPE, J
    MCGOFF, K
    EDSON, M
    KANEKO, T
    GREENFIELD, RS
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (06) : 367 - 374
  • [4] ROLE OF THE BP35 CELL-SURFACE POLYPEPTIDE IN HUMAN B-CELL ACTIVATION
    CLARK, EA
    SHU, G
    LEDBETTER, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) : 1766 - 1770
  • [5] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment
    Davis, TA
    Grillo-López, AJ
    White, CA
    McLaughlin, P
    Czuczman, MS
    Link, BK
    Maloney, DG
    Weaver, RL
    Rosenberg, J
    Levy, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3135 - 3143
  • [6] DEANS JP, 1993, J IMMUNOL, V151, P4494
  • [7] Rapid redistribution of CD20 to a low density detergent-insoluble membrane compartment
    Deans, JP
    Robbins, SM
    Polyak, MJ
    Savage, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 344 - 348
  • [8] TNF-induced shedding of TNF receptors in human polymorphonuclear leukocytes:: Role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase
    Dri, P
    Gasparini, C
    Menegazzi, R
    Cramer, R
    Albéri, L
    Presani, G
    Garbisa, S
    Patriarca, P
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (04) : 2165 - 2172
  • [9] Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains
    Field, KA
    Holowka, D
    Baird, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) : 4276 - 4280
  • [10] GOLAY JT, 1985, J IMMUNOL, V135, P3795